Georgetown University has recently received funding from the National Institutes of Health in order to advance cancer research, including breakthrough research on cancer cells' behavior and the "Hippo" pathway at the Georgetown Lombardi Comprehensive Cancer Center.Read More
Through testing mice that have an abnormality in certain common chromosomes that are found in prostate cancer, researches from the Georgetown Lombardi Comprehensive Cancer Center were able to prevent tumors from growing and spreading with the help of the drug YK-4-279. (Photo of lab mouse by Rama, courtesy of Wikimedia Commons).Read More
There are many well-known neurodegenerative diseases like Alzheimer's and Parkinson's that are caused by the loss of neurons which can lead to memory loss or the loss of nerve function. Neurodegenerative diseases can also occur from other diseases, such as HIV which can induce dementia. Researchers at Georgetown University in Washington D.C. have been studying different molecular mechanisms that contribute to Alzheimer's disease and HIV-induced dementia.Read More
The mosquito-borne disease malaria is a threat to the 3.4 billion people living in the 106 countries where malaria has not been eradicated. Many of the countries at risk are located in Africa and parts of Asia. Although it was eliminated from the United States in the 1950's, U.S. travels account for between 1,500 and 2,000 malarial cases annually. There are drugs that can treat the disease, however these drugs are not effective everywhere due to drug resistance.Read More
If you are a researcher searching for ways to spend time away from the lab and meet other researchers in Washington, D.C., our Georgetown University life science event is the perfect opportunity for you to meet researchers and other industry professionals while learning about the latest life science solutions available on the market. Biotechnology Calendar, Inc.’s Georgetown BioResearch Product Faire™ Event will take place on March 13th, 2014. Last year, this event attracted 122 attendees.
Lab suppliers interested in taking advantage of life science marketing opportunities at universities with a wealth of life science research funding may be interested in the latest NIH funding awarded to Georgetown University. The NIH awarded Georgetown University $6.4 million this year for its department of internal medicine. The funding organization within the NIH was the National Center for Advancing Translational Sciences.
Tags: 2014, 2013, Georgetown University, Washington DC, Northeast, D.C., Geotwn, BioResearch Product Faire Event, NIH funding, NIH grant, NIH award, life science marketing events, life science marketing opportunities
“Lombardi's mission is to prevent, treat and cure cancers, through cutting-edge research, expert and compassionate patient care, education of future cancer specialists, and service to the community,” says the Georgetown University Lombardi Comprehensive Cancer Center funding application and project abstract listed on NIH RePORTER. The Lombardi Comprehensive Cancer Center was recently awarded $1.4 million this year. “Lombardi is the only NCI-designated cancer center in the nation's capital and in the Washington metropolitan area. The District of Columbia has among the highest cancer mortality rates in the country. Thus, there is a clear need for an NCI-designated comprehensive cancer center that can bring a targeted, evidence-based strategy to cancer care and prevention to help improve the health of the community's residents.”
Researchers at Georgetown University conducted a study that suggests that undiagnosed pre-diabetes occurs at higher rate than was previously thought in people with Alzheimer’s disease. Dr. R. Scott Turner, director of the Georgetown University Medical Center’s Memory Disorders Program, brought people into the study who had mild to moderate Alzheimer’s disease so that he could investigate resveratrol, a compound found in red grapes and red wine. Resveratrol is thought to mimic the effects of a low calorie diet. When the study began, Dr. Turner said he was shocked by how many of the study’s participants had pre-diabetes.
A Georgetown University study published in the journal JAMA Pediatrics says that there is a great deal of evidence that suggests that probiotics should be used to protect prematurely born infants from a dangerous and often deadly disease. Dr. Dan Merenstein of Georgetown University was the study’s senior author. The nearly half-million babies born prematurely every year in the U.S. are at risk of developing necrotizing enterocolitis (NEC), which affects the gastrointestinal tract by infecting it and destroying the bowel. According to the Georgetown website, the Georgetown University researchers believe that probiotics, a useful bacteria type, can help protect the intestinal tract and should be used with all premature babies with NEC.